What causes bluish discoloration of the eyes (blue sclera)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bluish Discoloration of the Eyes (Blue Sclera)

Primary Cause

Blue sclera is primarily caused by osteogenesis imperfecta (OI), a genetic connective tissue disorder characterized by abnormal collagen type I production that results in thinning of the sclera, allowing the underlying uveal tissue to show through. 1

Major Etiologies

Genetic Syndromes

Osteogenesis Imperfecta (Most Common)

  • OI Type I: Blue sclera remains intensely blue throughout life in all affected children 1, 2
  • OI Types III and VII: Blue sclera present at birth but intensity fades by adolescence, with variable scleral hue in adulthood 1, 2
  • OI Type IV: Typically has normal sclerae, which is an important distinguishing feature 1
  • The blue discoloration results from decreased scleral thickness allowing visualization of the underlying choroidal pigment 3

Other Genetic Conditions

  • Ehlers-Danlos syndrome (vascular type/Type IV): Characterized by thin skin, easy bruising, and blue sclera 1
  • Loeys-Dietz syndrome: Features blue sclera along with arterial tortuosity and hypertelorism 1

Metabolic Bone Disorders

  • Hypophosphatasia: Defective bone mineralization presenting with blue sclera 1
  • Hypophosphatemic osteomalacia (rickets): Can present with blue sclera, osteomalacia, and poor growth 1

Physiologic Variants

  • Normal infants before 12 months of age can have blue sclerae 1
  • Preterm birth is associated with decreased bone mineralization that may contribute to blue sclera 1

Diagnostic Evaluation Algorithm

History Assessment

  • Family history of multiple fractures, early-onset hearing loss, abnormal dentition, blue sclera, and short stature suggests OI 1
  • Pregnancy and birth history, total parenteral nutrition, hepatobiliary disease, diuretic therapy, hypercalciuria, or corticosteroid use are relevant 1

Physical Examination

  • Assess for signs of fractures, growth parameters, skin bruising, dental abnormalities (dentinogenesis imperfecta), and hair abnormalities 1
  • Evaluate for other ocular abnormalities including corneal changes 1
  • In OI, look for the complete constellation: fractures, short stature, dentinogenesis imperfecta, and hearing loss 1

Laboratory Studies

  • Serum calcium, phosphorus, alkaline phosphatase levels, and urinary calcium excretion should be obtained 1
  • Vitamin D levels can help rule out metabolic bone disorders 1

Imaging

  • Radiographic studies to evaluate for fractures or bone abnormalities may be indicated 1

Genetic Testing

  • COL1A1/COL1A2 mutation testing is recommended when OI is suspected 1

Critical Clinical Pitfalls

Distinguishing OI from Non-Accidental Injury

  • In children with fractures and blue sclera, careful evaluation is needed to distinguish OI from non-accidental injury 1
  • The presence of blue sclera in infants with unexplained fractures may suggest OI rather than abuse 1

Age-Related Changes

  • Blue sclera intensity changes with age in certain OI types—what appears blue in infancy may normalize by adolescence in Types III and IV, but remains blue throughout life in Type I 2

Associated Ocular Complications

  • Almost every component of the eye can be affected in OI, including decreased corneal and scleral thickness 3
  • Patients are at risk for ruptures, lacerations, and other eye problems after minor trauma 3
  • Keratoconus can occur as an associated finding in OI, though less commonly documented 4

Management Considerations

  • Protective eyewear is recommended for OI patients to prevent accidental eye trauma 3
  • When ocular surgery is required, it should be approached with caution due to structural abnormalities 3
  • Corticosteroids may be used in treatment of non-infectious scleritis associated with blue sclera 1

References

Guideline

Evaluation and Treatment Approach for Bluish Sclera

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Natural history of blue sclerae in osteogenesis imperfecta.

American journal of medical genetics, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.